EGM
ORMP icon

Engineers Gate Manager’s Oramed Pharmaceuticals ORMP Stock Holding History

Engineers Gate Manager’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.1K Buy
+12,698
New +$50.5K ﹤0.01% 2117
2021
Q3 		– Sell
-22,310
Closed -$299K – 1882
2021
Q2 		$299K Buy
+22,310
New +$255K 0.02% 1143

Other funds holding ORMP

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Engineers Gate Manager's ORMP Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in Oramed Pharmaceuticals (ORMP) in Q2 2026: 12,698 shares worth $61.1K. The stake represents ﹤0.01% of the portfolio and ranks #2117 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in ORMP as recently as Q2 2021.

Engineers Gate Manager first reported a position in ORMP in Q2 2021 and has held it in 2 quarters since. The position peaked at $299K in Q2 2021. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

  • Engineers Gate Manager held 12,698 shares of Oramed Pharmaceuticals worth $61.1K as of Q2 2026.
  • Oramed Pharmaceuticals was a new Engineers Gate Manager position in Q2 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #2117 holding.
  • Engineers Gate Manager first reported a position in Oramed Pharmaceuticals in Q2 2021 and has held it in 2 quarters since.
  • Engineers Gate Manager's Oramed Pharmaceuticals position peaked at $299K in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.